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Abstract: Various etiological factors contributing to the development of mycotoxic 
nephropathy in farm animals and humans are reviewed. The possible synergistic effect 
between ochratoxin A (OTA) and other mycotoxins, as penicillic acid (PA) and fumonisin 
B1 (FB1), contributing to this nephropathy is also considered and discussed. The most 
convenient ways of prophylaxis and various preventive measures against OTA 
contamination of feeds or foods are reviewed. A reference is made concerning the most 
successful methods of veterinary hygiene control in the slaughterhouses in order to prevent 
the entering of OTA in commercial channels with a view to human health. The economic 
efficacy of these prophylactic procedures is also considered. An evaluation of human 
exposure to OTA is made.  
Keywords: mycotoxic nephropathy, Balkan endemic nephropathy, ochratoxin A, penicillic 
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Introduction  
The mycotoxic nephropathy (MN) is a renal disorder caused by alimentary ingestion of secondary 
fungal metabolites possessing nephrotoxic properties and encountered in feeds/foods/forages made 
mainly from cereals or fibrous plants, and kept in storehouse conditions and increased humidity. Since 
its discovering the disease has been described using various names: nephrosis provoked by moulds, 
chronic interstitial fibrosis of kidneys, chronic interstitial nephritis, etc. Recently, the terms 
“ochratoxicosis” and “mycotoxic nephropathy” are the most frequently used ones for describing this 
nephropathy.  
During the last years this kidney disease has gained high publicity in some countries with well 
developed stock-breeding (especially pig-breeding) as Denmark, Sweden, Bulgaria, etc. In order to 
prevent human exposure to various nephrotoxic mycotoxins, mainly ochratoxin A (OTA), via 
consuming the meat of animals with nephropathy, the timely diagnosis of disease during the meat 
inspection at slaughterhouses is very important. In such a way the exposure of humans to this very 
hazardous and relatively heat stable toxin from chicken/pigs meat can be prevented [1]. 
There are some variances in the manifestation of the disease, especially in the clinicomorphological 
picture , which in a lot of the cases is influenced by the secondary bacterial infections [2] as a result of 
the pronounced immunosuppression in the affected animals [2, 3, 4, 5, 6]. Therefore, this review paper 
could contribute to timely diagnostics of mycotoxic nephropathy in farm animals (MNFA) as well as 
could help the organization of the prophylactic measures against this disease. In addition, some 
information is given how to make an evaluation of human exposure to OTA on the base of the found 
concentrations of OTA in human serum via calculating the daily OTA intake of humans in endemic 
areas.  
1. Complex Etiology of MN 
Although many nephrotoxic fungal compounds such as fumonisins are known [7], only OTA and 
partly citrinin can be firmly associated with spontaneous cases of MN. Ochratoxins are a group of 
structurally related compounds. Between them, the first and the most toxic compound discovered is 
OTA, which was isolated from Aspergillus ochraceus and chemiclly defined in 1965 by several South 
African scientists [8-11]. OTA consists of a dihydroisocoumarin moiety linked through its 7-carboxyl 
group by an amide bond to one molecule of L-β phenylalanine (7-carboxy-5-chloro-8-hydroxy-3-4-
dihydro-3R-methylisocoumarin). Citrinin was discovered in 1931 by Hetherington and Raistrick, who 
isolated the compound from several strains of Penicillium citrinum [12].  
Fungi that produce OTA are widespread in nature and various foods or drinks [13, 14, 15], but 
commonly contaminate stored grain. Penicillium viridicatum, predominantly a storage fungus, is the 
mould that usually develops on grains at low temperatures and also is the major producer of OTA in 
the colder areas of the world (Northern Europe and Canada). On the other hand Aspergillus ochraceus 
probably is the most impotant producer of OTA in tropical and semitropical areas [16, 17]. However, 
the growth of A. ochraceus on natural substrates has not been associated with a natural occurrence of 
OTA. Not all isolates of P. viridicatum and A. ochraceus are OTA producers, but some of them 
produce other toxic compounds, e.g., citrinin, penicillic acid (PA), hydroxyaspergillic acid and 
secalonic acid [18]. Int. J. Mol. Sci. 2008, 9  580
 
A positive correlation has been observed between the frequency of spontaneous porcine 
nephropathy in Bulgaria and the rate of OTA in corresponding feed samples. However, the analysis for 
OTA of various feed samples from farms with high frequency of spontaneous mycotoxic porcine 
nephropathy (MPN) revealed that the values were substantially low and ranged from 38 to 552 (mean 
207.1 ± 65.14) ng/g for 1993 and from 42 to 427 (mean 114.06 ± 35.79) ng/g for 1994 respectively. 
These farms usually had a history of incorrect feed storage. Sometimes the problem seemed to come 
from certain feed plants whose grains, collected during moist and rainly days, had not been properly 
dried. All farms supplied by these plants subsequently produced some pigs with nephropathy and 
growth depression, but after changing the certain suspected feeds the problems with poor growth of 
pigs disappeared. As a whole, the frequency and duration of the observed nephropathy in different 
batches of slaughtered pigs varied significantly (from 1-2% up to 80-90% frequency) and have 
depended on the duration of feeding of various suspected feeds stored for a long time in poor 
conditions and at high humidity [18-21]. 
Figure 1. Range of enlargement and mottled or pale appearance of kidneys from pigs with 
MPN at age of 6-8 months taken at slaughtered time, including an example (left) with 
enlarged renal lymph nodes. 
 
 
It is important to mention that kidney damages in spontaneous MPN in Bulgaria (Figure 1) are more 
similar to those in Balkan endemic nephropathy (BEN) in humans, than in Danish MPN. For example, 
the fibrotic changes and contraction of kidneys in the end-stages of MPN in Bulgaria are very 
comparable to those in BEN in humans [1], whereas such changes are not seen in the classical 
description of MPN as made in Denmark. In addition to the contraction of kidneys in later stages of 
Bulgarian MPN and BEN, there are various other similarities between BEN in humans and Bulgarian 
MPN as the low contamination levels of OTA in feeds or foods and serum, neoplastic changes in 
kidneys (pigs – Figure 2) or urinary tract (humans), retention cyst formation in proximal tubules of 
kidneys, vascular lesions in kidneys, electron dense formations and myelin-like figures in 
mitochondria of epithelial cells (Figure 3). However, these pathological changes have not been 
observed in classical MPN as described in Denmark or elsewhere. This circumstance, in addition to 
low feed/food levels of OTA in Bulgarian MPN and BEN, suggest a possible interaction between OTA Int. J. Mol. Sci. 2008, 9  581
 
and other mycotoxins, which needs to be proved (Figure 3). Recently, it was found that 
pathomorphological changes, including electron-dense formation and myelin-like figures, induced in 
pig’s kidneys by combined exposure to such low contamination levels of OTA together with PA, are 
more similar to those in spontaneous MPN in Bulgaria than to classical Danish MPN [22].  
Figure 2. Kidney with neoplastic tissue (fibroadenoma) - spontaneous case of MPN in 
Bulgaria. 
 
All feed samples originating from farms with high frequency of spontaneous avian nephropathy in 
Bulgaria were also positive for OTA and similarly to pig farms, the levels of OTA were substantially 
low (the values ranged from 90.8 to 310 ng/g (mean 196.2 ng/g ±45.9). The nephropathy in chickens 
was usually observed during the spring and summer, similarly to porcine nephropathy and in the same 
regions as well. The occurrence of nephropathy in different batches of slaughtered chickens varied 
from 1-2 per cent up to 90-100 per cent. The continuance of this nephropathy, also differed widely 
from one month to about 5-6 months or even throughout a year [23]. 
It is known that experimental pigs exposed to OTA contaminated feed at levels of about 200 ppb 
develop only microscopic lesions after a period of 3-4 months [24, 25]. The average contamination 
level of OTA in Bulgarian feeds for pigs in 1993 only exceeded 200 ppb OTA [18]. On the other hand, 
the low contamination levels of OTA in pigs/chicks feeds suggest a possible synergism between OTA 
and other compounds produced by the same ochratoxinogenic fungi. It is very likely that feeds contain 
other nephrotoxic mycotoxins or compounds which enhance the toxicity or produce a synergistic 
interaction with OTA [such as PA, fumonisin B1 (FB1), citrinin, viomelein, xanthomegnin etc]. 
Additive or synergistic interactions of these compounds have not been proved for all combinations. 
Several years ago, it has been found that the toxicity of various strains of the same Aspergillus 
ochraceus group is very different, independently of the capacity of OTA production [22, 26, 27]. A 
potent synergistic effect was found between OTA and PA, mycotoxins produced by the same 
ochratoxinogenic fungi, when the same mycotoxins were given simultaneously to pigs and chickens 
[22, 26-30]. The production of multiple toxins by a single organism, such as Aspergillus ochraceus 
(which produces OTA and PA simultaneously), or by mixture of fungi presents a problem that has not 
been sufficiently investigated. Such mixtures of toxins may have additional or synergistic effects in 
farm animals. PA was suspected to be carcinogenic [31,32] and was found to have DNA-attacking 
ability in the rec assay [33] as well as to induce chromosome aberations [34]. Some data suggest that Int. J. Mol. Sci. 2008, 9  582
 
feed contamination levels of PA itself up to 4000 ppb have little toxicity (mostly hepatotoxicity) and 
do not adversely affect body or organ weights or biochemical parameters in chickens [35]. Only DNA 
breaks in mammalian cell lines [36, 37] and an inhibition of rat liver glutathione S-transferase activity 
in crude extracts in vitro [38] as well as PA-induced hepatobiliary excretory dysfunction [39] and liver 
hemorrhages [40] have been found so far. The higher toxicity of OTA in all above mentioned studies 
might be due to synergistic toxic effects between OTA and PA, as has been reported in mice [41, 42] 
and in poultry [28]. Previous studies have suggested an important role of the pancreatic enzyme 
carboxypeptidase A in the detoxification of OTA in the small intestine [43, 44]. Parker and colleagues 
[45] showed that PA inhibits carboxypeptidase activity in vitro and in vivo and such inhibition may 
significantly impair the primary detoxification of OTA in the intestinal tract and so be partly 
responsible for the enhanced toxicity of OTA observed in combination with PA [22, 26-30]. The PA-
induced hepatobiliary excretory dysfunction [39] may also result in decreasing of hepatobiliary 
excretion of OTA. Such synergism between OTA and PA or other mycotoxins under field conditions 
may be responsible for the spontaneous mycotoxic nephropathy in Bulgaria, which can be caused by 
relatively low contamination levels of OTA in feed [18, 21, 23]. This could explain why the low levels 
of OTA in Bulgarian feeds for pigs [18, 21], chickens [23] or humans [1] have such high toxic effect 
on kidneys, when ingested with spontaneous contaminated feeds. The concentration of OTA in feeding 
forages is probably more important than that of PA, because the higher contamination levels of PA 
(60000 ppb PA in combine with 1000 ppb OTA) [46] have not been able to produce more significant 
toxic effects. This findings clearly suggest that the increase in OTA-toxicity is probably due to 
impaired detoxification of OTA via PA-inhibited carboxypeptidase activity in the intestinal tract. 
Figure 3. Role of OTA in the renal diseases MPN and BEN. 
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Several years ago, Stoev and collaborators [22] induced macroscopic kidney damages in pigs fed on 
a mouldy diet containing low levels of OTA (180 ppb) in combination with PA for a 3 months feeding 
period, whereas microscopic lesions in kidneys in the same experiment were observed in pigs fed on a 
diet containing only 90 ppb OTA in combination with PA. The observed changes were similar to those 
caused in pigs at the end of the 4-month period of exposure to higher levels (markedly above 200 ppb) 
of pure OTA in feed [24]. It is therefore important to investigate the effect of combined administration 
of OTA and other mycotoxins, produced by the same ochratoxinogenic fungi as occur in the field.  
In combined administration of OTA and PA much lower concentrations of OTA (about 100 ppb) 
are enough for a significant toxic effect in chickens, expressed by degenerative changes in internal 
organs, by a depletion of cells in lymphoid tissue and decrease of lymphoid organ's weight as well by 
known changes in various biochemical parameters [28]. Moreover, degenerative and weight changes 
in kidneys, liver and lymphoid organs as well as immunosuppression were seen recently in chickens at 
only 0.2 or 0.3 ppm OTA in combination with PA [26, 27, 29, 30, 47], whereas such changes had been 
seen in chickens exposed to significantly higher levels of pure OTA (about 4 ppm) in feed [48-51]. 
According to other authors [46] a similar but less pronounced synergistic toxic effect has been 
observed at higher contamination levels of OTA (1000 ppb). The mentioned above low experimental 
levels of OTA correspond very well to the feed levels of OTA found in spontaneous cases of 
mycotoxic avian nephropathy (MAN) in Bulgaria (0.09-0.31 ppm) [23], which suggests a possible 
multicausal nature of MAN in Bulgaria. 
Furthermore, to ascribe the source of OTA to the A. ochraceus group of fungi is unwise because 
ochratoxinogenic forms are isolated so rarely [18, 52]. In such a way the source of OTA in Bulgaria is 
generally obscure. Therefore, it is already of great importance to carry out more mycological 
investigations in order to isolate the ochratoxinogenic fungi in Bulgarian feeds. In addition, the overall 
concentration of OTA in feed samples (from 0.38 to 0.552 ppm) were substantially lower than the 1 to 
2 ppm required to reproduce MPN/MAN of severity similar to that observed in spontaneous cases [18, 
21, 23, 53]. It seems, therefore, that the MPN/MAN in Bulgaria may have a multitoxin or multifactor 
etiology, because it cannot be explained by the concentration of OTA alone. The multimycotoxin 
etiology of MPN/MAN in Bulgaria is recently confirmed as high contamination levels of PA (838,6 ± 
223,9 μg/kg - 88% positives) and FB1 (5564,1 ± 584 μg/kg - 96% positives) in Bulgarian feed samples 
from farms with mycotoxic porcine nephropathy were found, whereas the levels of OTA (188,8 ± 27,3 
μg/kg - 100% positives) in the same feeds were consecutively lower (unpublished personal data). A 
similar multimycotoxin etiology was also found for South African MPN as the same mixture of 
mycotoxins (67,8 ± 39,2 μg/kg OTA - 83,3% positives; 149,2 ± 64,1 μg/kg PA - 41,7% positives, 
5046,2 ± 1301 μg/kg FB1 - 80% positives) was found in South African feed samples from pig farms 
with nephropathy problems (unpublished personal data).  
Some mycological investigations of OTA-contaminated feeds in Bulgaria revealed the common 
presence of P. aurantiogriseum complex [18], which is a potent producer of PA [54]. PA is produced 
by numerous species of Penicillium (especially P. aurantiogriseum) and Aspergillus at temperatures 
ranging from 4°C to 30°C, with the maximum rate of production occurring at about 25°C [55]. The 
production of PA decreased sharply at low oxygen concentrations, while fungal growth was not 
noticeably influenced [56]. PA progressively form complexes with compounds containing -SH radicals 
[57, 58]. The rate of toxin coupling with -SH radicals increases with pH as well as in high temperature 
[58]. The resulting complexes are much less toxic than the uncoupled molecules, resulting in actual Int. J. Mol. Sci. 2008, 9  584
 
detoxification. As a result, this toxin usually accumulates at relatively low temperatures during the 
winter at which detoxification is more reduced than toxin production [55]. That could explain why 
Bulgarian nephropathy in pigs/chickens was usually observed during the spring and summer. 
It has recently been found that administration of P. polonicum extract (not containing OTA) to rats 
can provoke profound and persistent histopathological damages such as apoptic and karyomegalic or 
mitotic changes in the nuclei of tubular epithelium in kidneys of rats, including DNA-adducts 
formation [59]. The same P. polonicum strain, which is a common food/feed spoilage mould in warm 
temperate latitudes, has been found as a frequent contaminant in Bulgarian feeds, suspected of causing 
spontaneous porcine nephropathy [18, 52]. Moreover, the P. polonicum extract given to rats probably 
contained PA. It is known that the P. aurantiogriseum group (including P. polonicum strain) is a 
potent producer of PA, which can also provoke DNA breaks in mammalian cell lines as has been 
reported [36]. In such a way it could appear that the source of PA in Bulgarian feeds can be different 
from the source of OTA. Also, the same changes (apoptosis and karyomegaly in tubular epithelium), 
provoked by P. polonicum extract, could be induced by another unknown mycotoxin; this would be of 
interest, because the same mycotoxin could be partly responsible for the nephrotoxic damages 
described in Bulgarian nephropathy. Moreover, the quiet apoptosis, induced by P. polonicum 
nephrotoxin, could be a possible model for the cryptic and clinically-silent onset of renal atrophy in 
the idiopathic Balkan endemic nephropathy in humans [60]. On the other hand, it has been reported 
that OTA has a high potential to induce apoptosis and DNA-adducts in vitro [61, 62] and in rodent in 
vivo [63]. Also, Rahimtula et al. [64] showed that lipid peroxidation in kidney microsomes was 
enhanced by OTA and produced malondialdehyde. The same compound could give DNA adducts [61, 
62]. In such a way, the extent to which OTA may interact with other components of commercial 
chicken/pig rations or human food compounded from agricultural produce may also influence the 
significance of the relatively lower doses of OTA that commercial chickens [23, 27], pigs [18, 21] or 
humans [1] may encounter in some feed/food. 
2. Methods of Prophylaxis and Various Preventive Measures in Regard to the Main Etiological 
Agent of MN - OTA  
Various different strategies can be employed to reduce human/animal exposure to OTA or to reduce 
its toxic effects when it is fed to animals. The same include the use of management practices to prevent 
the production of OTA by the storage fungi, the feeding of contaminated grain to animal species that 
are less susceptible to the toxic effects of OTA, such as ruminants, modification of the diet to promote 
enhanced hydrolysis of OTA in the gastrointestinal tract or reduced absorption, the use of a feeding 
regimen that can counteract the metabolic effects of OTA, the use of various procedures that can 
destroy OTA, such as physical and chemical methods for decontamination of commodities as well as 
the use of various feed additives, which can protect against the toxic effects of OTA etc. [65].  
Gastrointestinal microorganisms have a large effect on the disposition of OTA because they 
promote the hydrolysis of OTA to its nontoxic form OTα. This is particularly important in ruminants 
[66] and therefore they are less susceptible to OTA-toxicity. In addition, the type of diet also affects 
the disposition of OTA in the rumen [67, 68]. Ruminal fluid obtained from hay-fed animals (pH 7.0) 
was able to hydrolyze OTA to ochratoxin α (OTα)  in vitro five times faster than ruminal fluid 
obtained from grain-fed animals (pH 5.5). Disappearance of OTA from the rumen and the Int. J. Mol. Sci. 2008, 9  585
 
corresponding formation of OTα was also much faster for hay-fed than for grain-fed sheep. The 
bioavailability of OTA in sheep fed grain was 4.3 times greater than that in sheep fed hay. Thus, the 
rumen of the sheep has an important role in the detoxification of OTA and the type of diet affects the 
rate and extent of this process. As a result, the bioavailability of OTA, and probably the toxicity to 
ruminants, is decreased. In addition, the intestinal microflora of nonruminant animals, also affect the 
bioavailability of OTA, because the microorganisms in the intestines and particularly in the caecum 
and large intestine are also responsible for the hydrolysis of OTA to its nontoxic form OTα [66].  
Another way to prevent the production of OTA is prevention of the growth of the storage fungi. The 
most important factors in safeguarding stored feedstuffs/foodstuffs from OTA prodution by moulds are 
their moisture content (water activity) and temperature [56]. Large quantities of OTA can be produced 
at intermediate and high ambient temperatures and high moisture contents by species belonging to the 
Penicillium and Aspergillus, whereas at lower ambient temperature the toxin can be produced by 
Penicillium spp. only. In addition, the moulds in the corn when stored at 21% moisture produced a 
large quantity of OTA (about 3.6 ppm), whereas none of this toxin was found in corn stored at 16% 
moisture [69]. A similar situation is seen in the barley stored at 16% and 20% moisture [70]. These 
and some other studies indicate that fungi in cereal grains stored at moisture contents lower than 15% 
generally do not produce OTA, which suggests that the moisture content in the cereal grains have to be 
decreased under 15% via various drying procedures before storage [71]. Storage at higher moisture 
levels requires that grain be maintained under anaerobic conditions, which prevent growth of fungi. 
Otherwise, a combination of mould inhibitors and sterilization techniques, possibly coupled with the 
inoculation of nontoxigenic competitive microflora, have to be applied to prevent the growth of OTA-
producing fungi.  
Chelack and collaborators [72, 73] have used another way to control the growth of OTA-producing 
fungi. They demonstrated that gamma or electron beam irradiation is a highly effective means of 
destroying spores from some OTA-producing fungi as A. alutaceus [72, 73]. Various other types of 
radiation (X-rays, ultraviolet light, microwaves) in addition to γ-irradiation are also used as a means 
for detoxification of mycotoxins as well as to control the growth of fungi [74, 75].  
Leitao and collaborators [76] demonstrated that phosphine (PH3) was effective at inhibiting both 
fungal growth and sterigmatocystin production by A. versicolor, and this could be considered as 
another specific way to control the growth of OTA-producing fungi.  
For foods with pH values from 5 to 6, such as the cereals or sorghum, the antimicrobial agent (food 
additive) that is able to prevent the growth and OTA-production by Aspergillus and Penicillium 
species, is methyl paraben or potassium sorbate. Small concentrations of these compounds are able 
completely to inhibite the growth by both genera of fungi and their OTA-production. At pH 4.5, as 
occurs in silage, fungal growth and OTA-production was completely inhibited by 0.02% potassium 
sorbate, 0.7% methyl paraben, and 0.2% sodium propionate [77].  
The use of various procedures that can destroy OTA, such as physical and chemical methods for 
decontamination of commodities can be considered as another important way for safely utilizing of 
feedstuffs. Madsen and collaborators [78] reported that treatment of OTA-contaminated barley with 
5% NH3 for 96 h at 70°C or warming of grain to 105°C in the presence of 0.5% NaOH as well as 
autoclaving at 132°C for 0.5 h can destroy the main part of OTA in the barley, but such treatments are 
not practical and are not able effectively reduce the concentration of OTA in grain.  Int. J. Mol. Sci. 2008, 9  586
 
Chelkowski and collaborators [79] reported that treatment of OTA-contaminated grain with 
ammonia reduced OTA concentrations to undetectable levels. Moreover, weight gains of chickens fed 
the OTA-contaminated grain were markedly decreased, whereas there was no reduction in weight 
gains when the chickens were fed the OTA-contaminated grain that had been ammoniated. They 
concluded that ammoniation of grain not only detoxifies several mycotoxins, including OTA, but also 
inhibits mould growth [79]. Feeding studies have shown no toxic effects related to the ammoniation 
process, but there are some changes in the nutritional quality of the feed, such as a decrease in lysine 
and sulfur containing amino acids [80]. In addition, adequate aeration after ammoniation is necessary 
for acceptance of the feed by animals. However, other than ammoniation, many of the techniques 
proposed to remove mycotoxins are currently perceived as impractical, ineffective, and/or potentially 
unsafe for largescale use [81].  
Rotter and collaborators [82] demonstrated that inoculation of barley with a Lactobacillus species 
followed by ensiling (decreasing of pH) reduced the concentration of OTA by approximately 50% 
[82]. 
Also, Scott [83] reported that OTA is completely destroyed during malting of barley [83]. 
According to Laciakova and collaborators [84] formic acid of 0.25% concentration degraded OTA 
after 3 h exposure, propionic and sorbic acids in 1% concentration after 24 h exposure and benzoic 
acid in 0.5% concentration after 24 h exposure [84]. 
Several different approaches have been used to reduce OTA absorption, including the use of 
hydrated sodium calcium aluminosilicate (HSCAS), bentonite, charcoal, and cholestyramine. The 
addition of HSCAS (1%) and bentonite (1% and 10%) to a diet containing OTA had no effect on OTA 
concentration in swine blood, serum, tissues, and bile. The addition of 1% activated charcoal to the 
diet, in contrast, caused a slight decrease in the concentration of OTA in swine blood, whereas 10% 
charcoal decreased the concentration of OTA in blood, liver, kidney, spleen, and heart by 50% to 80% 
[85]. However, the supplementation of OTA-contaminated diet with activated charcoal was considered 
as an impractical method of reducing OTA toxicity in chicks or pigs that were continuously consuming 
OTA [86].  
Cholestyramine, in contrast to the nonspecific absorbent discussed above, seems to be an effective 
absorbent of OTA in the gastrointestinal tract of nonruminant animals. Cholestyramine is a 
commercial anion exchange resin that has been shown to reduce blood OTA concentrations by 50%, 
when it was included in 0.5% in a rat diet containing 1 ppm OTA. In addition, the faecal excretion of 
OTA was significantly increased in rats given a single oral dose of OTA, which were fed on diet 
containing cholestyramine [85].  
Another way to reduce OTA-toxicity supposed a good understanding of the mechanisms of OTA-
toxicity: inhibition of phenylalanine metabolizing enzymes (having in mind a phenylalanine moiety of 
OTA), enhancing of lipid perooxidation, and inhibition of mitochondrial ATP production. This 
approach includes an addition of phenylalanine and protein to the diet. It is well known that the 
phenylalanine moiety of OTA competitively inhibits at least two enzymes: phenylalanyl-tRNA 
synthetase and phenylalanine hydroxylase, resulting in reduced protein synthesis and altered rates of 
tyrosine production from phenylalanine. The addition of phenylalanine to cell cultures containing 
OTA in vitro [87] or coadministration of phenylalanine with OTA [88, 89] reduced OTA-induced 
inhibition of protein synthesis. In vivo experiments show that injection of phenylalanine also prevented 
OTA-induced immunosuppression in mice [90, 91, 92] and partially reduced teratogenesis in rats [93]. Int. J. Mol. Sci. 2008, 9  587
 
The phenylalanine has to be used in 5:1 molar ratio towards OTA [94], because it had been found that 
phenylalanine given in higher doses as 10:1 molar ratio, provides only a slight protection against OTA, 
because of increasing the absorption of OTA from the stomach and intestine. Moreover, the higher 
supplementation of pure phenylalanine in chick diets contaminated with OTA also tended to create an 
amino acid imbalance, which reduced b. w. gain and feed conversion efficiencies [95, 96]. These 
studies suggest that little or no benefit is obtained by supplementing OTA-contaminated diets with 
phenylalanine.  
The concentration of protein in the diet of growing chicks was also shown to ameliorate the toxicity 
of OTA [97, 98]. The consumption of high-protein diets (26%) by growing chicks over a three-week 
period compared to a diet containing a lower concentration of protein (14%) decreased the toxicity of 
5 ppm OTA in diet as indicated by rate of growth, mortality and relative organ weights of chicks [97, 
98]. This treatment, however, may not be practical because a large change in the protein concentration 
in diet may be costly and produces relatively small benefits  
The ascorbic acid supplementation (300 mg/kg) of laying hen diet that contained 3 ppm OTA has 
been reported to have a good protective effect against OTA-action and can partially ameliorate OTA-
toxicity (including the negative effect of OTA on the eggs production and on the weight of the eggs) 
[99, 100]. The mechanism of the protective effect is not clear but it is supposed to affect the 
production of lipid peroxides by OTA and to improve the membrane integrity of cell organelles, which 
is always affected by OTA-action [22].  
The use of various feed additives can also protect against the toxic effects of OTA and can reduce 
farm losses from a decrease of weight gain in stock chicks avoiding the rejecttion or condemnation of 
OTA-contaminated feed [27, 30, 94]. Sesame seed (rich in proteins - about 20% and relatively rich in 
L-β phenylalanine - about 4.3%), given in 8% to the feed, offered a cheaper agronomic additive to 
supply animals with phenylalanine and thereby to protect against toxicity of OTA [94]. It might also 
avoid the increase of OTA-absorption from the stomach and intestine provoked by the pure 
phenylalanine in feeds [101]. Simultaneously, the increase of urinary excretion of OTA in presence of 
phenylalanine [101] could be preserved in a later stage. Moreover, the sesame seed (8% to the feed) 
increases the energy metabolism in animals [94], which usually is disturbed by OTA [102]. 
Roxazyme-G (Hofmann La Roche, Grenzach-Wyhlen, Austria) is a polyenzyme complement 
produced by fungi "Trichoderma", which contains: cellulase, xylanase, endo-beta 1,3-1,4 glucanase, 
pectinase and amylase. Roxazyme-G, given in concentration 0.2g/kg feed, was reported to improve 
digestive dissimilation of polysaccharides to easily assimilated substances, that could improve 
utilization of feed by increasing digestible energy production by 8-13%, thereby counteracting OTA 
impairment of energy production in chicks [94]. 
Artichoke-extract is a complex containing compounds which might protect against OTA 
intoxication [26, 27, 30, 94]. The 5% total water-extract of artichoke (Cynara scolymus L), prepared as 
a steam infusion from dried leaves of artichoke and given to chicks in concentration 5 ml/kg.b.w. via 
the feed or water, usually contains various biologically active compounds: cynarine, flavonoids, 
cynaropicrin, dehydrocynaropicrin, grosheimin as well as a high content of calcium and ascorbic acid 
[103]. It has been recommended as a diuretic agent in cardiac and renal insufficiency, and might 
accelerate the urinary route of excretion of OTA [26, 27, 30]. Moreover, the cynarine content in such 
extract stimulates metabolism of cholesterol, decreases serum urea and lipids, improves diuresis and 
increases biliary secretion, which probably augment the hepatobiliary route of excretion of OTA (OTA Int. J. Mol. Sci. 2008, 9  588
 
is mainly eliminated via bile and urine) and thereby has been found to protect against OTA 
nephrotoxicity and hepatotoxicity [26, 27, 29, 30, 94] as well as against the immunosuppressive effect 
of OTA [27, 94, 104] or against OTA-induced anaemia [27]. Cynarine and flavonoids as well as some 
medical preparations prepared from artichoke-extract (chophytol and chophytamine) have a potent 
hepatoprotective effect against hepatotoxic damage [105-107]. Also, antipermeability and 
vasoconstrictive effects of water extract of artichoke could decrease oedema in various internal organs 
provoked by OTA [18, 27, 29, 30, 94]. The high content of calcium and vitamin C in the steam extract 
probably has also a protective effect against OTA-toxicity via improving membrane integrity of cell 
organelles and skeleton-strength of the chicks or via some other ways [27, 29, 94], since some authors 
reported that ascorbic acid supplementation (300 mg/kg) of laying hen diet that contained OTA (3.0 
mg/kg) partially reduced OTA-toxicity [100].  
Rosallsat, which is another plant extract (a polyextract of bulbus Alii Sativi and seminum Rosai 
canina), was seen also to have a protective effect against OTA-toxicity, when it was given per os in 
0.6 ml per kg body mass daily as a supplement to the feed [26]. The Rosallsat is a new natural galenic 
phytosubstance of balanced polyvitamine, phytoncide and steroid-saponine composition - described 
completely in patent No 98915 BG / 1994, which contains biological active compound allicin (12.08 
mg/g) as well as large quantities of vitamins A (0.0332 mg/g), F (0.8112 mg/g), E (0.1548 mg/g) and 
furostanic sapogenine of C57H96O30 [26, 29, 30]. The allicin in that study was formed in advance and 
included in a natural oil extract in commercial lots stabilized with natural antioxidants [26]. This is an 
advantage when compared with fresh or dried garlic cloves since thiosulphinate is hardly formed in the 
pH conditions of the stomach and intestine after eating fresh or dried garlic. The precise mechanism of 
protection of Rosallsat against OTA-toxicity has not been investigated in depth, but it is supposed that 
the biological active compound allicin and the high quantities of vitamins A, F and E in this plant 
extract probably are of great importance [26, 29, 30]. The Rosallsat is found to inhibit lipid 
peroxidation (unpublished personal data) and in such a way prevents one of the mechanism of OTA 
toxicity [64].  
It was found that the intensity of macroscopical and histopathological changes, the deviations in 
relative organs' weight and body weight (Table 1), the decrease of antibody titer (Table 2), as well as 
the intensity of changes in various haematological and biochemical parameters (Table 3) were slighter 
in chicks treated with some antidotes (5% artichoke-extract, 0.02% Roxazyme-G, 8% sesame seed, 
0.0025% phenylalanine) in addition to 5 ppm OTA than in chicks only treated with 5 ppm OTA. In 
chicks of groups treated with sesame seed or artichoke-extract the described changes, especially the 
antibody titer against Newcastle disease, were more similar to those ones observed in chicks exposed 
to an approximately 5 times lower contamination levels of OTA (1 ppm) (Table 2). Moreover, it 
appeared that all of the mentioned above antidotes, used as supplements to the feeds, especially sesame 
seed and artichoke-extract, had a potent protective effect against OTA-induced toxicity and could be 
used as a practical approach for safely utilizing of OTA-contaminated feed [94]. In such a way the 
rejection or condemnation of such feed will be avoided as well as there will be no need to eliminate 
OTA from the feed, if its contamination levels are similar to these encountered in the practice 
(normally upto 1-2 ppm OTA). However, in the pigs which are more sensitive to OTA, the levels of 1 
ppm OTA can be more dangerous [2, 22, 108] and this requires additional experimentation to clarify 
the antidote effect of the same additives in these animals. 
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Table 1. Mean values of body weight (b.w.) after consecutive two-week periods in groups 
of chicks treated with OTA and various antidotes [94]. 
OTA  antidotes  1 day  14 day  28 day  42 day 
(ppm)    b.w. (g)  b.w. (g)  b.w. (g)  b.w. (g) 












5 ppm  Roxazyme G  80.5 ±2.0 237.0
1c ±6.2 380.5
3c ±14.7 691.0
3c ±10.9  
5 ppm  Sesame seed  81.5 ±2.4 224.5
2c ±8.3 368.5
3c ±21.8 704.0
3c ±16.5  
5 ppm  Artichoke-extract  79.5 ±3.3 219.5
3c ±6.3 364.5
3c ±15.0 646.5
3c ±22.0  
Control -  82.0  ±2.5 255.0
c ±5.6 509.0
c ±14.9 836.0
c ±21.1  
Chicks number  -  20  20  20  20 
* - SEM (standard error of the mean)
 
1 – Significant difference (p < 0.05) 
2 – Very significant difference (p < 0.01) 
3 – Extremely significant difference compared to the control group (p < 0.001) 
c - Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001) 
 
Table 2. Mean values of haemagglutinin inhibiting antibody titers (HIAT) in groups of 
chicks treated with OTA and various antidotes - on day 21 after vaccination against 
Newcastle disease (28 days from the beginning of the experiment) [94]. 
 OTA  Antidotes  HIAT  Number   
 (ppm)    (HU/ml)  of  chicks 
 1  ppm  -  340.0
c ±70.5* 20 
 5  ppm  -  7.1
3 ±1.0 20 
 5  ppm  L-β phenylalanine  31.4
3c ±4.0 20 
  5 ppm  Roxazyme G   16.4
3 ±4,8 20 
  5 ppm  Sesame seed  280.0
c ±40.0 20 
 5  ppm  Artichoke-extract  150.03
c ±19.1 20 
 Control  -  353.3
c ±57.9 20   
* - SEM (standard error of the mean)
 
3 – Extremely significant difference compared to the control group (p < 0.001) 
c - Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001) 
 
A protective effect against OTA-induced decrease of total serum protein was found in chicks of all 
antidote-treated groups mentioned above, but a protection against the increase of serum glucose was 
only seen in groups treated with Roxazyme-G and artichoke-extract. Also, a protective effect against 
OTA-indiced increase of serum creatinine and urea was seen in all antidote-treated groups especially 
on day 70 [94]. In addition, the protective effect against the increase of serum values of uric acid and 
creatinine was strongest in the group treated with sesame seed (Table 3).  Int. J. Mol. Sci. 2008, 9  590
 
However, it appeared that the protective effect of phenylalanine was slighter than expected one in 
contrast to some of the other studied antidotes [94]. The main reason for that could be the 
circumstance that phenylalanine was found to increase the absorption of OTA from the stomach and 
intestine as well as the gastrointestinal transit of OTA. This resulted in eightfold and fourfold higher 
levels of OTA in serum and liver of mice, respectively, during the first 12 h [101], which could also 
increase its elimination. Therefore, phenylalanine has to be given after changing the feed source and 
stopping OTA-exposure of animals [109]. 
Table 3. Mean serum values of total protein, urea and creatinine in groups of chicks 
treated with OTA and various antidotes (70th days) [94]. 
 OTA  Antidotes  Total protein  Urea  Creatinine  Number 
(ppm)   (g/l)  (mmol/l)  (µmol/l)  of  chicks 
1 ppm  -  31.27
1c ±1.60 2.46
3b ±0.061 124.0
c ±3.5 10   
5 ppm  -  23.26
3 ±0.69 2.86
3 ±0.088 514.4
3 ±65.0 10   
5 ppm  L-β phenylalanine  25.96
3a ±1.00 1.88
c ±0.149 309.5
3b ±16.8 10   
5 ppm  Roxazyme G  27.66
3c ±0.55 2.48
3c ±0.032 240.6
3c ±16.7 10   
5 ppm  Sesame seed  26.87
3c ±0.54 2.51
3b ±0.047 191.9
3c ±15.2 10   
5 ppm  Artichoke-extract  26.49
3b ±0.62 2.52
3b ±0.022 275.1
3b ±20.4 10   
Control -  36.54
c ±1.29 1.81
c ±0.070 119.8
c ±2.4 10   
* - SEM (standard error of the mean)
 
1 – Significant difference compared to the control group (p < 0.05) 
2 – Very significant difference compared to the control group (p < 0.01) 
3 – Extremely significant difference compared to the control group (p < 0.001) 
a – Significant difference compared to the 5 ppm group without antidote (p < 0.05) 
b – Very significant difference compared to the 5 ppm group without antidote (p < 0.01) 
c - Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001) 
 
The strong protection of Roxazyme-G against OTA-induced increase of serum glucose could be due 
to the improved energy metabolism, whereas the protection of artichoke-extract against that increase 
could be due to an improvement of diuresis [27]. The protective effect of sesame seed and 
phenylalanine against OTA-provoked immunosuppression in humoral immune response and changes 
in differential WBC count [94] might be due to an improvement of protein synthesis, which usually is 
disturbed by OTA and subsequently, an improvement of OTA-induced delay of the division of the 
cells of the immune system. 
It is known that OTA induces an increase of the weight of the organs taking part in its 
detoxification or elimination (kidneys and liver) as well as a decrease of the lymphoid organs' weight 
and body weight, whereas some of the studied feed additives (5% artichoke-extract, 0.02% Roxazyme-
G, 8% sesame seed, 0.0025% phenylalanine) significantly protects against these weight changes [94] 
as the protective effect of sesame seed and Roxazyme-G against these weight changes was stronger 
than the protective effect of artichoke-extract and phenylalanine.  
In other experiments [26, 30, 110] it was also confirmed that Artichoke-extract has a significant 
protective effect against OTA-toxicity. In the same studies, another plant extract Rosallsat was also Int. J. Mol. Sci. 2008, 9  591
 
seen to protect against OTA-toxicity, expressed by statistically significant protection against the OTA-
induced changes in serum levels of total protein, uric acid and cholesterol (Table 4). The serum levels 
of uric acid, which were most significantly influenced of the quantity of OTA in fed forages, usually 
give an exact assessment of the impairment of kidney function in chicks [49]. The absence of a 
confident increase in that parameters in Artichoke-extract and Rosallsat treated groups suggests a 
slight impairment in kidney function in these groups and confirms the protective effects of these feed 
additives against OTA-toxicity. On the other hand, the protective effect of Artichoke-extract and 
Rosallsat on the liver function may contribute to the higher cholesterol levels in the groups of chicks 
treated with the same antidotes [26]. In addition, the toxicological investigations in the same 
experiments revealed that the contamination levels of OTA in kidneys are lower in chicks treated with 
Artichoke or Rosallsat in addition to OTA than in chicks only treated with the same feed level of OTA 
[30]. 
Table 4. Mean serum values of cholesterol and uric acid in groups of chicks treated with 
OTA (130, 305 and 790 ppb) and PA (1000-2000 ppb), and various antidotes (70th day) 
[26]. 
 OTA  Antidotes  Cholesterol  Uric  acid  Number 
 (ppb)    (mmol/l)  (µmol/l)  of  chicks 
 130  ppb  -  3.90
1b ±0.20 211.7
c ±16.4 5 
 305  ppb  -  3.75
2a ±0.17 458.0
3 ±23.3 5 
 790  ppb  -  3.11
3 ±0.12 534.1
3 ±24.8 5 
 790  ppb  Artichoke-extract  3.80
1a ±0.22 222.4
c ±29.2 5 
 790  ppb  ROSALLSAT
®  4.63
a ±0.51 182.2
c ±28.8 5 
 Control  -  5.09
c ±0.34 162.6
c ±14.6 10 
* - SEM (standard error of the mean)
 
1 – Significant difference compared to the control group (p < 0.05) 
2 – Very significant difference compared to the control group (p < 0.01) 
3 – Extremely significant difference compared to the control group (p < 0.001) 
a – Significant difference compared to the 790 ppb group without antidote (p < 0.05) 
b – Very significant difference compared to the 790 ppb group without antidote (p < 0.01) 
c - Extremely significant difference compared to the 790 ppb group without antidote (p < 0.001) 
3. A Possible Hygiene Control in Regard to OTA 
By 1990, at least nine countries have regulations for OTA levels or had proposed and enforced 
official limits for OTA. Regulatory control of nephrotoxic mycotoxins in animal feeds in European 
countries has been summarized by van Egmond [111] and later by Boutrif and Canet [112]. On the 
other hand, European Union decided on an official limit for OTA in cereals designed for direct 
consuming of about 5 μg ОТА/kg [113]. The official limits for OTA in cereals in some countries can 
be seen in various FAO reports and commonly ranged between 2 μg/kg (Switzerland) and 20 μg/kg 
(Czech Republic), and rarely reached up to 50 μg/kg (Uruguay) [112].  
In countries with wide spreading of MPN and MAN residues of OTA were often found in animal 
tissues samples during the meat inspection [18, 23, 114, 115, 116].  Int. J. Mol. Sci. 2008, 9  592
 
The contamination levels of OTA in liver, muscles and fat tissues of pigs can be easily found using 
the following experimental calculations [117]: 
 
liver  -0,7 + 0,7 X 
muscles  -0,6 + 0,4 X 
fat tissue  -0,8 + 0,3 X, 
where “X” is the concentration of OTA in kidneys in µg/kg and X≥2 
 
By 1990, at least nine countries have regulations for OTA levels or had proposed and enforced 
official limits for OTA. Regulatory control of nephrotoxic mycotoxins in animal feeds in European 
countries has been summarized by van Egmond [111].  
Because of the absence of correlation between macroscopic changes and concentration of OTA in 
pig kidneys it is very difficult to prevent the exposure of humans to the toxin from pork by 
toxicological investigations of "pale or mottled kidneys" as it is occurred in Denmark. The practice in 
Denmark of monitoring kidney tissues in only those pigs that have detectable kidney lesions could not 
provide a good basis for condemnation of carcases, because the intake of OTA may have not been of 
sufficient duration to produce detectable lesions. Therefore, the regulations in Denmark, according to 
which all enlarged and mottled kidneys are investigated for residues of OTA at slaughter time and all 
carcasses, whose kidneys contained OTA levels above 10 µg/kg [112] are condemned are not very safe 
and clever, because macrscopic changes in kidneys can be found only after 1-3 months OTA exposure 
via the feeds [22, 118]. Some investigations made by various authors revealed that at least 1-2 months 
are needed to develop characteristic macroscopical renal lesions in pigs exposed to natural or 
experimental OTA contaminated barley [24, 119]. Unfortunately, characteristic for MPN macroscopic 
changes in kidneys can not be found after a shorter period of OTA exposure via the feeds even with 
such high levels as 1000 ppb OTA [120] and animal products containing dangerous OTA 
contamination levels could easily pass meat inspection at slaughterhouses [22]. On the other hand the 
renal lesions in kidneys (mottled appearance) induced at an early age do not disappear when the pigs 
are fed on OTA-free diet, which also indicates the lack of efficiency of such control system and the 
implementation of some unnecessary toxicological investigations, which could be avoided [21, 22]. In 
spite of the toxicological investigations of such kidneys OTA-contaminated pork may enter the human 
food chain and thus represents a potential public health hazard [21]. Since the toxin is relatively heat 
stable [121], a limited occurrence of OTA might anticipated in prepared food from such animals.  
Because of the assumption that mycotoxins and especially OTA are involved in etiology of Balkan 
endemic nephropathy [1, 122-124] the exposure of humans to this very hazardous toxin from pork or 
chicken meat (by the way "feed – pork/chicken - food") need to be prevented. A much better procedure 
for preventing the exposure of humans to the toxin from meat would be a toxicological analysis of a 
few blood samples of pigs/chicken from farms, suspected of having MN, several weeks (in pigs) or 
several days (in chicken) before slaughter and a change in the feed source for a week (pigs) or for 2-3 
days (chicken), if it is necessary. Also, the period of feed deprivation of pigs/chicken before slaughter 
could be prolonged [21, 23]. Because of the short half-life of OTA in pigs (72 - 120 hours) and 
especially in chickens (4 hours) [125] its concentration in blood and various tissues quickly decreases 
after changing the feed source or after prolonging the period of feed deprivation before slaughtering. 
Thus, the loss of condemnation of pig/chicken production would be prevented and a better procedure Int. J. Mol. Sci. 2008, 9  593
 
(than toxicological invesigations of "enlarged mottled kidneys" accepted in Denmark) would be 
realized for preventing the exposure of humans to OTA from meat [21-23, 114]. The preventive 
measures in already slaughtered chicks could include condemnation and removing of the kidneys and 
liver, where OTA is accumulated [23].  
However, having in mind that a combined administration of OTA and other mycotoxins such a PA, 
often occurrs in the practice and synergistic effects between OTA and the same mycotoxins are 
reported, the lower contamination levels of OTA in food/feed would be also very dangerous for human 
and animal health [22, 30].  
4. A Possible Involvement of Mycotoxins in Etiology of Balkan Endemic Nephropahy and 
Evaluation of Human Exposure to OTA 
Balkan Endemic Nephropathy (BEN) in humans is another renal disorder having a similar 
pathological characteristics as MPN. It is most commonly observed in farmers at ages between 30 and 
50 years, has oligosymptomatic clinical picture, silent onset and poor prognosis, progresses very 
slowly and manifests itself when the function of majority of nephrons have become impaired [126]. At 
this time there is agreement that the disease represents an unusual type of chronic interstitial 
nephropathy of unknown etiology, although there is an assumption that mycotoxins are involved [123]. 
The disease has a strict endemic character and is encountered in the rural populations in Bulgaria, 
Romania and ex-Yugoslavia. So far, at least 20,000 persons have been suffered from BEN. The total 
number of people at risk has been estimated to approximately 100,000 [126]. 
The high humidity and the poor food storage conditions in endemic villages, the low living and 
hygienic standard as well as the consumption of home prepared food from own crops - bread, bean and 
others [123, 127] correspond to the fact that the moulds producing mycotoxins contaminate mostly 
home produced grain feeds stored in bad conditions and high humidity, while the situation in the towns 
is markedly different - foodstuff supply is centralized and quality controlled (that explain the family 
character of BEN only in rural inhabitants). Also, the focality and zonality (characteristic for BEN) are 
typical for mycotoxicosis (i. e. endemic dissemination) and are determined mainly by the ecological 
conditions of the regions which are optimal for the development of the corresponding fungi and by the 
altitude [128]. The seasonal and yearly variations in incidence and prevalence of the disease and OTA-
content in the human food as well as the positive correlation between the excess rainfall and the 
number of patients suffering from BEN, who died during the following two years [129], probably 
because of additional intake of moulded food (provoking new degenerative damages in kidneys and 
impairing the disease state), give additional support to the mycotoxin hypothesis of BEN [1]. 
However, the etiology of the disease is still unknown in spite of various etiological investigations 
including the search for heavy metals, trace elements, infectious agents and genetic factors as well as 
various bacteriological, toxicological, and hydrological investigations of water [123]. 
Nephrotoxic mycotoxin OTA has been suggested as one of possible disease determinants of BEN 
based on a comparison of morphological and functional kidney impairment between OTA-induced 
MPN and BEN [122]. In endemic areas, OTA has been found in human blood as well as in human 
food [123, 126, 130, 131, 132] and in animal feed in higher concentrations than in nonendemic areas 
[133] or the countries without BEN. It is important to mention that the feed levels of OTA in animal 
feeds from endemic for MPN regions (38-552 ppb) are approximately the same as in the foods from Int. J. Mol. Sci. 2008, 9  594
 
endemic for BEN regions (10-890 ppb), which additionally suggest a possible common etiology [1]. 
The mean concentration of OTA in human blood in Bulgarian-endemic areas ranges respectively from 
20 µg/l for 1986 to 27.2 µg/l for 1989 [130, 132]. These high concentrations suggest for a possible role 
of OTA in a disease causation of BEN. However, OTA was detected in a concentration range of 5-100 
µg/l only in 0.4 to 2.5% of a total 13,797 analysed blood samples from 14 endemic areas in Slavonski 
Brod (Croatia) during 9-year (1981-1989) period and in a concentration range 2-50 µg/l in 0.2 to 4.5% 
of a total 6,910 analysed serum samples from endemic village of Kaniza over the 10-year (1985-1994) 
period [126]. These concentrations of OTA in human blood are significantly lower towards those ones 
in Bulgaria [134], but correspond quite well to the prevalence of the disease (ranged between 1% and 
4.5% during the last 15 years) and the incidennce of newly recorded BEN-suffering patients (ranged 
between 1.0 and 2.5 per thousand) in the same endemic areas. 
The disease is also closely associated with a high frequency of carcinoma in the renal pelvis, ureter 
and urinary bladder [135, 136], which could be due to the carcenogenicity of nephrotoxic mycotoxin 
OTA [125, 137, 138], but the working group that evaluated the carcinogenicity of OTA to humans 
could not draw any conclusion [34]. Interestingly, some tumors in kidneys and bladders from patients 
living in areas associated with Balkan Endemic Nephropathy, have been found to contain DNA 
adducts similar to those obtained from the kidneys of mice exposed to OTA [139], which provides new 
evidence of the possible role of OTA in the development of tumors of the urinary tract. Moreover, 11 
of 31 patients with urinary tract tumors in France exhibited a OTA-specific DNA adduct pattern 
similar to those found in Bulgarians suffering from BEN, OTA-treated rodent and Bulgarian pig 
suffering from nephropathy. OTA was present in the blood in the half of the same patients [140]. It 
was found that changes in debrisoquine 4-hydroxylation in vivo can occur in the rat in response to 
mouldy food [141] and patients suffering from BEN and/or upper urothelial tumors were more 
frequently extensive metabolizers of debrisoquine (DB) [142]. A recent study in Egypt revealed a 
positive correlation between OTA and the end stage renal disease (ESRD) or urothelial tumors in 
humans. Patients with ESRD as well as patients with nephrotic syndrom or urothelial tumors have 
significantly higher mean concentrations of OTA in blood (between 0.52 and 2.19 ng/ml) and urine 
(between 0.36 and 3.09 ng/ml) than patients from control groups (between 0 and 0.08 ng/ml in blood 
and between 0.01 and 0.26 ng/ml in urine) [143]. It is established that OTA decreases natural killer 
cell activity by the specific inhibition of endogenous interferon levels [144]. As natural killer cells are 
involved in the distribution of tumor cells, the ability of OTA to modulate the activity of these cells 
might contribute to its capacity to induce renal and hepatic carcinomas [2].  
Recently, it has been found that OTA has a significantly longer plasma half-life in humans (33.55 
days) than in animals [145]. A slow excretion of OTA suggests a tendency to an increase of toxin 
levels in the serum as well as assumes a very constant rate of OTA in human blood for a long period of 
time, even after repeated exposure to very low concentrations [146]. In such way the humans are more 
influenced by the dose and less influenced by the frequency, duration and quantity (if the quantity of 
the toxin ingested is comparatively low) of OTA exposure than other species, because in the humans 
OTA has a very constant and continuous effect on the proximal tubules even in little amounts, because 
of the very low unbound (free) fraction of OTA in blood. It can be supposed that only the free OTA in 
the macroorganism has a toxic effect on the tissues as well that continuous persistence of OTA in 
human blood and its slow excretion via kidneys may be influenced on the slow progression of BEN. Int. J. Mol. Sci. 2008, 9  595
 
Thus, consumption of food containing very low concentrations of OTA over a long period of time may 
become toxicologically significant [1]. 
A method is also presented for calculating the daily consumption of OTA through various food 
products on the basis of the measured content in plasma, even though the toxicokinetic constants are 
unknown. The renal filtration rate of OTA in humans, calculated from the glomerular filtration rate of 
inulin and the free fraction of OTA is 0.67 ml/kg body weight per day. The kidney filtration has been 
found to correspond to the total plasma clearance of OTA (almost 100%) in monkeys, but only to 10% 
in mice, rats and pigs. The equation: K0 = Clp.Cp/A shows the relationship between continuous intake 
(K0, ng/kg b. w. per day), the plasma clearance (Clp, ml/kg b. w. per day), the plasma concentration of 
OTA (Cp, ng/ml) and the bioavailability (A, proportion of toxin absorbed - about 50%). [147]. The 
same equation was used to calculate the daily intake of OTA from the concentration of the toxin in 
plasma of humans in endemic regions in Bulgaria. The daily intake of humans, calculated on the basis 
of the average plasma levels of OTA in endemic area in Bulgaria was found to be between 26.8 and 
36.4 ng/kg b. w. as can be seen from Table 5 [1, 124]. It is important to mention, that this calculation 
should give an underestimate of the intake, since the value used for plasma clearance only involves 
glomerulal filtration. This underestimate could be as much as ten times, if the OTA clearance in man is 
more similar to those in rat, mouse and pig than that in monkey.  
Table 5. Calculation of the daily intake of OTA in patients suffering from BEN in endemic 
of BEN areas and in healthy patients from nonendemic areas in Bulgaria [1, 124]. 
 Areas  Year  Positive  Cp  Reference K0 
  samples  (ng/ml)  (ng/kg b. w. 
  (%)  per day)  
 1986  23.3  20.0  [132]  26.8   
 endemic of BEN  1989  29.2  27.2    36.4  
   1990 25.0  25.0    34.2   
 
   1986 7.7  10.0  [132]  13.4   
  nonendemic  1989  6.6  0 > 2    0 > 2.7  
   1990 6.6  8.0    10.7   
Cp - average concentration of OTA in plasma 
K0 - average daily intake 
 
Because of the increase of scientific reports on OTA contamination in beverages and many kinds of 
food, the WHO/FAO Joint Expert Committee on Food Additives (JECFA) assessed the available 
information and proposed 112 ng/kg b.w. as a provisional tolerable weekly intake (PTWI) for OTA 
[148]. That corresponds to about 16 ng/kg body weight per day. Having in mind the strong 
carcinogenic effect of OTA its PTWI was later decreased to 100 ng/kg b.w., which corresponds to 
about 14 ng/kg body weight per day [149].  
It can be concluded that the average daily intakes in the endemic areas in Bulgaria from 26.8 ng/kg 
b. w. for 1988 [1, 124], 36.4 for 1989 and 34.2 for 1990 respectively, exceeds strongly PTWI (100 
ng/kg b. w. or 14 ng/kg b. w. per day), proposed by the JECFA [149]. JECFA bases its calculation of Int. J. Mol. Sci. 2008, 9  596
 
the tolerable intake mainly on the nephrotoxicity of OTA and does not address the question of the 
toxin's carcenogenic effect. Kuiper-Goodman and Scott, however, regard the carcinogenic effect as the 
most important effect and base their analysis on this. Tolerable daily intakes (TDIs), depending on the 
method used and calculated on the base of carcinogenic effect of OTA, range from 0.2 to 4,2 ng/kg b. 
w. It can be concluded that the maximum tolerable daily intake of OTA is 5 ng/kg b. w. [109]. It can 
be seen that the average daily intake of the endemic and in some extent nonendemic areas exceeds 
strongly the TDI calculated on the base of cancerogenic effect of OTA [1].  
The performed calculations on TDIs show that OTA contamination of food and feed constitutes a 
public health problem of unknown dimensions. Therefore, it is quite relevant to investigate to what 
extent OTA is hazardous to humans. Because of the high thermal stability of this mycotoxin, ordinary 
cooking does not eliminate it. Thus, limited occurrence of OTA might be anticipated in prepared food.  
Recently, however, more and more evidences appeared, that exposure to more than one mycotoxin 
may be an important factor in etiology of BEN [52] and MPN [18]. Moreover, the synergism between 
OTA and various other mycotoxins such a PA, citrinin or FB1 in field conditions may be responsible 
for an enhanced toxicity of OTA [22, 27, 30]. Due to the potent toxic and synergistic effects of OTA 
and PA or citrinin [22, 150] as well as between OTA and FB1 [151, 152], simultaneous exposure to 
those mycotoxins might be an important factor for development of chronic renal diseases in animals 
and humans, especially after long-term exposure. The same mycotoxins were recently found in high 
contamination levels (especially FB1 and PA) in most of the feeds originated from farms with 
mycotoxic porcine or avian nephropathy in Bulgaria (unpublished personal data). Because of that it is 
of great importance to investigate the combined effect between OTA and other mycotoxins produced 
by the same species as it is occurred in field conditions.  
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